Works by van der Waart, Anniek

Results: 13

Good manufacturing practice production of an off-the-shelf CD34+ progenitor-derived NK cell product with preserved anti-tumor functionality post-infusion in NOD/SCID/IL2Rgnull mice.

Published in:

Cellular & Molecular Life Sciences, 2025, v. 82, n. 1, p. 1, doi. 10.1007/s00018-025-05727-4

By:

Hooijmaijers, Laura;
Vidal-Manrique, Marcos;
Spils, Bart;
van Ens, Diede;
Rodriguez, Verónica Castaño;
Hobo, Willemijn;
de Goede, Anna L.;
van Dorp, Suzanne;
Jansen, Joop H.;
van der Waart, Anniek B.;
de Jonge, Paul K. J. D.;
Dolstra, Harry

Publication type:

Article

CD34+ progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rgnull mice.

Published in:

OncoImmunology, 2021, v. 10, n. 1, p. 1, doi. 10.1080/2162402X.2021.1981049

By:

Van der Meer, Jolien M. R.;
de Jonge, Paul K. J. D.;
van der Waart, Anniek B.;
Geerlings, Alexander C.;
Moonen, Jurgen P.;
Brummelman, Jolanda;
de Klein, Janne;
Vermeulen, Malou C.;
Maas, Ralph J. A.;
Schaap, Nicolaas P. M.;
Hoogstad-van Evert, Janneke S.;
Ottevanger, Petronella B.;
Jansen, Joop H.;
Hobo, Willemijn;
Dolstra, Harry

Publication type:

Article

Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8+ T cells for adoptive immunotherapy.

Published in:

OncoImmunology, 2018, v. 7, n. 10, p. 1, doi. 10.1080/2162402X.2018.1488565

By:

Mousset, Charlotte M.;
Hobo, Willemijn;
Fredrix, Hanny;
Jansen, Joop H.;
Dolstra, Harry;
van der Waart, Anniek B.;
Ji, Yun;
Gattinoni, Luca;
De Giorgi, Valeria;
Allison, Robert D.;
Kester, Michel G. D.;
Falkenburg, J. H. Frederik;
Schaap, Nicolaas P. M.

Publication type:

Article

Combined IL-15 and IL-12 drives the generation of CD34 -derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer.

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1017701

By:

Cany, Jeannette;
van der Waart, Anniek B;
Spanholtz, Jan;
Tordoir, Marleen;
Jansen, Joop H;
van der Voort, Robbert;
Schaap, Nicolaas M;
Dolstra, Harry

Publication type:

Article

Time to Akt.

Published in:

OncoImmunology, 2015, v. 4, n. 5, p. 0, doi. 10.1080/2162402X.2014.1003016

By:

van der Waart, Anniek B;
Hobo, Willemijn;
Dolstra, Harry

Publication type:

Article

Comprehensive Phenotyping of T Cells Using Flow Cytometry.

Published in:

Cytometry. Part A, 2019, v. 95, n. 6, p. 647, doi. 10.1002/cyto.a.23724

By:

Mousset, Charlotte M.;
Hobo, Willemijn;
Woestenenk, Rob;
Preijers, Frank;
Dolstra, Harry;
van der Waart, Anniek B.

Publication type:

Article

Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3167, doi. 10.1007/s00262-021-02899-3

By:

van Eck van der Sluijs, Jesper;
van Ens, Diede;
Thordardottir, Soley;
Vodegel, Denise;
Hermens, Inge;
van der Waart, Anniek B.;
Falkenburg, J. H. Frederik;
Kester, Michel G. D.;
de Rink, Iris;
Heemskerk, Mirjam H. M.;
Borst, Jannie;
Schaap, Nicolaas P. M.;
Jansen, Joop H.;
Xiao, Yanling;
Dolstra, Harry;
Hobo, Willemijn

Publication type:

Article

Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8+ T cells.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2259, doi. 10.1007/s00262-020-02612-w

By:

Mousset, Charlotte M.;
Hobo, Willemijn;
de Ligt, Aafke;
Baardman, Sjoerd;
Schaap, Nicolaas P. M.;
Jansen, Joop H.;
van der Waart, Anniek B.;
Dolstra, Harry

Publication type:

Article

siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8 T cells in NOD/SCID/IL2Rg(null) mice.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 645, doi. 10.1007/s00262-015-1668-6

By:

van der Waart, Anniek;
Fredrix, Hanny;
van der Voort, Robbert;
Schaap, Nicolaas;
Hobo, Willemijn;
Dolstra, Harry

Publication type:

Article

Increased peritoneal TGF-b1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancer.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1448041

By:

Maas, Ralph J. A.;
Hoogstad-van Evert, Janneke S.;
Hagemans, Iris M.;
Brummelman, Jolanda;
van Ens, Diede;
de Jonge, Paul K. J. D.;
Hooijmaijers, Laura;
Mahajan, Shweta;
van der Waart, Anniek B.;
Hermans, Charlotte K. J. C.;
de Klein, Janne;
Woestenenk, Rob;
van Herwaarden, Antonius E.;
Schaap, Nicolaas P. M.;
Rezaeifard, Somayeh;
Tauriello, Daniele V. F.;
Zusterzeel, Petra L. M.;
Ottevanger, Nelleke;
Jansen, Joop H.;
Hobo, Willemijn

Publication type:

Article

Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice.

Published in:

PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0064384

By:

Cany, Jeannette;
van der Waart, Anniek B.;
Tordoir, Marleen;
Franssen, Gerben M.;
Hangalapura, Basav N.;
de Vries, Jolanda;
Boerman, Otto;
Schaap, Nicolaas;
van der Voort, Robbert;
Spanholtz, Jan;
Dolstra, Harry

Publication type:

Article

Decreased Levels of Circulating IL17-Producing CD161+CCR6+ T Cells Are Associated with Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation.

Published in:

PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0050896

By:

van der Waart, Anniek B.;
van der Velden, Walter J. F. M.;
van Halteren, Astrid G. S.;
Leenders, Marij J. L. G.;
Feuth, Ton;
Blijlevens, Nicole M. A.;
van der Voort, Robbert;
Dolstra, Harry

Publication type:

Article

Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivo.

Published in:

Cellular & Molecular Life Sciences, 2023, v. 80, n. 10, p. 1, doi. 10.1007/s00018-023-04923-4

By:

van Eck van der Sluijs, Jesper;
van Ens, Diede;
Brummelman, Jolanda;
Heister, Daan;
Sareen, Aastha;
Truijen, Lisa;
van Ingen Schenau, Dorette S.;
Heemskerk, Mirjam H. M.;
Griffioen, Marieke;
Kester, Michel G. D.;
Schaap, Nicolaas P. M.;
Jansen, Joop H.;
van der Waart, Anniek B.;
Dolstra, Harry;
Hobo, Willemijn

Publication type:

Article

Works by van der Waart, Anniek

Good manufacturing practice production of an off-the-shelf CD34<sup>+</sup> progenitor-derived NK cell product with preserved anti-tumor functionality post-infusion in NOD/SCID/IL2Rg<sup>null</sup> mice.

CD34<sup>+</sup> progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg<sup>null</sup> mice.

Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8<sup>+</sup> T cells for adoptive immunotherapy.

Combined IL-15 and IL-12 drives the generation of CD34 -derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer.

Time to Akt.

Comprehensive Phenotyping of T Cells Using Flow Cytometry.

Clinically applicable CD34<sup>+</sup>-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.

Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8<sup>+</sup> T cells.

siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8 T cells in NOD/SCID/IL2Rg(null) mice.

Increased peritoneal TGF-b1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancer.

Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rg<sup>null</sup> Mice.

Decreased Levels of Circulating IL17-Producing CD161<sup>+</sup>CCR6<sup>+</sup> T Cells Are Associated with Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation.

Human CD34<sup>+</sup>-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8<sup>+</sup> T cell and NK cell responses in vitro and in vivo.